Journals / Türk Hematoloji Onkoloji Dergisi / 2005 / Cilt: 15 - Sayı: 2

Potential risk factor of interleukin-10 gene polymorphism in acute myelogenous leukemia

Interlökin 10 gen polimorfizmi akut myeloid lösemi gelişiminde bir risk faktörü olabilir

Pages
57–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that IL- 10 -1082 GCC/ATA polymorphism were significantly higher in the patient with AML group than the healthy control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute leukemias are a heterogeneous group of disorders of the pluripotent stem cell.
📊
Key Findings & Data:The study included 23 patients with the diagnosis of AML and 60 healthy controls.
💡
Conclusion & Impact:It was found that IL- 10 -1082 GCC/ATA polymorphism were significantly higher in the patient with AML group than the healthy control group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Polimorfizm · genetik · Risk faktörleri

Abstract

Acute leukemias are a heterogeneous group of disorders of the pluripotent stem cell. In current study we investigated the association of the cytokine gene polymorphisms with the development of acute myelogenous leukemia (AML). The study included 23 patients with the diagnosis of AML and 60 healthy controls. All genotyping (TNF- α, TGF- β, IL-10, IL-6, IFN- γ) studies were performed using sequence specific primers PCR (PCR-SSP). The cytokine genotyping results of the patients were compared to those of the healthy controls. It was found that IL- 10 -1082 GCC/ATA polymorphism were significantly higher in the patient with AML group than the healthy control group. On the other hand, IL-10 -1082 ACC/ATA polymorphisms were significantly lower in the AML group than the healthy control group. It was found that IFN- γ+874 T/A polymorphism was correlated with white blood cell count. These results suggest that IL-10 GCC/ATA polymorphism is a potential risk factor for AML, whereas IL-10 ACC/ATA polymorphism is a possible protective factor.

Özet

Akut lösemi pluripotent stem hücrelerin oluşturduğu bir hastalık grubudur. Bu çalışmada sitokin gen polimorfizmi ile akut myeloid lösemi (AML) gelişimi arasındaki ilişki araştırılmıştır. Çalışma grubu AML tanısı almış 23 hasta ve 60 sağlıklı kontrolden oluşturulmuştur. Araştırılan gen polimorfizmleri (TNF- α, TGF- β, IL-10, IL-6, IFN- γ) sekans spesifik primerler kullanılarak PCR (PCR-SSP) yöntemi ile çalışılmıştır Sağlıklı kontrol grubu ile AML’li hasta grubunun sitokin gen polimorfizmleri karşılaştırıldığında hasta grupta IL-10 –1082 GCC/ATA polimorfizminin istatistiksel olarak anlamlı derecede yüksek, IL-10 –1082 ACC/ATA polimorfizminin ise az olduğu saptanmıştır. IFN-gama +874 T/A polimorfizmi lökosit sayısı ile ilişkili bulunmuştur. Bu bulgular IL-10 –1082 GCC/ATA polimorfizminin AML oluşumunda bir risk faktörü, IL- 10 –1082 ACC/ATA polimorfizminin ise koruyucu bir faktör olabileceğini göstermektedir.

🔖

Cite This Article

BAŞTÜRK, B., EVKE, E., KARAKUŞ, S., TUNALI, A. (2005). Potential risk factor of interleukin-10 gene polymorphism in acute myelogenous leukemia. Türk Hematoloji Onkoloji Dergisi, Cilt: 15 - Sayı: 2, 57–62. https://ajindex.com/articles/394733

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Graf M, Hecht K, Reif S, et al. Expression and prognostic value of hemopoetic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Eur J Haematol 72:89-106, 2004
  2. Guo H, Qiao Z, Zhu L, et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation. Am J Hematol 75:78-83, 2004
  3. Bidwell J, Keen L, Gallagher G. et al. Cytokine gene polymorphism in human disease. Genes and Immunity 1: 3-19, 1999
  4. Warzocha K, Ribeiro P, Bienvenu J. et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood 91: 3574-3581, 1998
  5. Beutler B, Cerami A. The Biology of cachectin/ TNF-α primary mediator of the host response. Annu Rev Immunol 7: 625-655, 1998
  6. Bidwell J.L, Wood N.A, Morse H.R, et al. Human cytokine gene nucleotide sequence aligments. Eur J Immunogenet 26:135-223, 1998
  7. Pravica V, Asderakis A, Perrey C. In vitro production of IFN-γ correlates with CA repeat polymorphism in IFN-γ gene. Eur J Immunogenet 26:1-3, 1999
  8. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the IL-10 gene promoter. Eur J Immunogenet 24:1-8, 1997
  9. Fishman D, Faulds G, Jeffery R, et al. Novel polymorphisms in the interleukin-6 gene: Their effect on IL-6 transcription, plasma IL-6 levels and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376, 1998
  10. Awad RA, Webber S, Boyle G, et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 20:265, 2001
  11. Akalin E, Murphy B. Gene polymorphisms and transplantation. Current Oppinion Immunology 13:572-76, 2001
  12. Bidwell J, Keen L., Gallagher G, et al. Cytokine gene polymorphisim in human disease: on line data base. Genes and Immunity 1:3-19, 1999
  13. Hersh EM, Whitecar JP, Mc Credie K.B, et al. Chemotherapy, immunocompetence, immunosupression and prognosis in acute leukemia. N Engl J Med 285:1211-1220, 1971
  14. Buggins AG, Milojkovic D, Arno MJ, et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 15: 6021-30, 2001
  15. Kiertscher SM, Luo J, Dubinett M. Tumors promote altered maturation and early apoptosis of monocyte-derived dentritic cells. J Immnuol 164:1269-1275, 2000
  16. Chang HM, Paulson